Terbinafine-Associated Hepatotoxicity
- 1 May 2003
- journal article
- case report
- Published by Elsevier in The Lancet Healthy Longevity
- Vol. 325 (5), 292-295
- https://doi.org/10.1097/00000441-200305000-00008
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Terbinafine Hepatotoxicity: Case Report and Review of the LiteratureAmerican Journal of Gastroenterology, 1998
- Hepatitis associated with terbinafine therapy: three case reports and a review of the literatureClinical and Experimental Dermatology, 1998
- Oral Terbinafine: A New Antifungal AgentAnnals of Pharmacotherapy, 1997
- Case Report: Terbinafine-Induced Prolonged Cholestasis with Reduction of Interlobular Bile DuctsDigestive Diseases and Sciences, 1997
- Terbinafine-induced cholestatic liver diseaseJournal of Hepatology, 1996
- Terbinafine-associated hepatic injuryJournal of Hepatology, 1994
- Hepatitis associated with terbinafine treatment.BMJ, 1993
- Short-duration therapy with terbinafine for dermatophyteonychomycosis: A multicentre trialBritish Journal of Dermatology, 1992
- TerbinafineDrugs, 1992
- Inhibition of squalene epoxidase by allylamine antimycotic compounds. A comparative study of the fungal and mammalian enzymesBiochemical Journal, 1985